Drugs / CSL830
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03177005 | — | — | Joshua S. Jacobs, MD | Approved for marketing | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL830 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03177005 ↗ |